Dose and time responses of vitamin D biomarkers to monthly vitamin D3 supplementation in overweight/obese African Americans with suboptimal vitamin d status: A placebo controlled randomized clinical trial

BMC Obesity

Volumn 2, Issue 1, 2015, Pages

  Bhagatwala, Jigar ^a   Zhu, Haidong ^a   Parikh, Samip J ^a   Guo, De Huang ^a   Kotak, Ishita ^a   Huang, Ying ^a   Havens, Robyn ^a,b   Pham, Michael ^a   Afari, Eric ^a   Kim, Susan ^a   Cutler, Christopher ^b   Pollock, Norman K ^a   Dong, Yutong ^a   Raed, Anas ^a   Dong, Yanbin ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b AUGUSTA UNIVERSITY   (United States)

Author keywords

4000 IU vitamin D; African Americans; Dose response vitamin D; Monthly vitamin D; Overweight obese

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; CALCITRIOL; COLECALCIFEROL; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS; PLACEBO;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD SAMPLING; BODY MASS; CALCIUM URINE LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; QUALITY CONTROL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION;

EID: 84962846452     PISSN: None     EISSN: 20529538     Source Type: Journal    
DOI: 10.1186/s40608-015-0056-2     Document Type: Article

References (40)

1. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001-2006. NCHS data brief. 2011(59):1-8.
2. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48-54. doi:10.1016/j.nutres.2010.12.001.
3. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab. 2010;95(10):4584-91. doi:10.1210/jc.2010-0606.
4. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. The American journal of clinical nutrition. 2000;72(3):690-3
5. Gallagher JC, Yalamanchili V, Smith LM. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J Steroid Biochem Mol Biol. 2013;136:195-200. doi:10.1016/j.jsbmb.2012.12.003 PMID: 23246640; PubMed Central PMCID: PMC3686842.
6. Ross AC. The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr. 2011;14(5):938-9. doi:10.1017/S1368980011000565.
7. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713-6. doi:10.1007/s00198-005-1867-7.
8. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21(7):1151-4. doi:10.1007/s00198-010-1285-3.
9. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010;9(11):709-15. doi:10.1016/j.autrev.2010.06.009.
10. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. doi:10.1210/jc.2011-0385.
11. Talwar SA, Aloia JF, Pollack S, Yeh JK. Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr. 2007;86(6):1657-62 PMID: 18065583; PubMed Central PMCID: PMC2581841.
12. Gallagher JC, Jindal P, Lynette MS. Vitamin D does not Increase Calcium Absorption in Young Women: A Randomized Clinical Trial. J Bone Miner Res. 2013. doi:10.1002/jbmr.2121.
13. Ng K, Scott JB, Drake BF, Chan AT, Hollis BW, Chandler PD, et al. Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. Am J Clin Nutr. 2013. doi:10.3945/ajcn.113.067777.
14. Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab. 2011;96(3):E436-46. doi:10.1210/jc.2010-1886 PMID: 21159838; PubMed Central PMCID: PMC3047227.
15. Ginde AA, Wolfe P, Camargo Jr CA, Schwartz RS. Defining vitamin D status by secondary hyperparathyroidism in the U.S. population. J Endocrinol Invest. 2012;35(1):42-8. doi:10.3275/7742.
16. Saito H, Kusano K, Kinosaki M, Ito H, Hirata M, Segawa H, et al. Human fibroblast growth factor-23 mutants suppress Na +-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem. 2003;278(4):2206-11. doi:10.1074/jbc.M207872200.
17. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113(4):561-8. doi:10.1172/JCI19081 PMID: 14966565; PubMed Central PMCID: PMC338262.
18. Ramon I, Kleynen P, Body JJ, Karmali R. Fibroblast growth factor 23 and its role in phosphate homeostasis. Eur J Endocrinol. 2010;162(1):1-10. doi:10.1530/EJE-09-0597.
19. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, et al. Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem. 2005;280(4):2543-9. doi:10.1074/jbc.M408903200.
20. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington (DC)1997.
21. Murdoch DR, Slow S, Chambers ST, Jennings LC, Stewart AW, Priest PC, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA. 2012;308(13):1333-9. doi:10.1001/jama.2012.12505.
22. Schoenmakers I, Francis RM, McColl E, Chadwick T, Goldberg GR, Harle C, et al. Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D(3). Trials. 2013;14:299. doi:10.1186/1745-6215-14-299 PMID: 24041337; PubMed Central PMCID: PMC3848647.
23. Saadi HF, Dawodu A, Afandi BO, Zayed R, Benedict S, Nagelkerke N. Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women. The American journal of clinical nutrition. 2007;85(6):1565-71.
24. Hollis BW, Kamerud JQ, Kurkowski A, Beaulieu J, Napoli JL. Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. Clinical chemistry. 1996;42(4):586-92.
25. Uzum AK, Salman S, Telci A, Boztepe H, Tanakol R, Alagol F, et al. Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term. Eur J Endocrinol. 2010;163(5):825-31. doi:10.1530/EJE-10-0591.
26. Harris RA, Pedersen-White J, Guo DH, Stallmann-Jorgensen IS, Keeton D, Huang Y, et al. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens. 2011;24(5):557-62. doi:10.1038/ajh.2011.12 PMID: 21311504; PubMed Central PMCID: PMC3812921.
27. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc. 2007;55(2):234-9. doi:10.1111/j.1532-5415.2007.01048.x.
28. Chel V, Wijnhoven HA, Smit JH, Ooms M, Lips P. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int. 2008;19(5):663-71. doi:10.1007/s00198-007-0465-2 PMID: 17874029; PubMed Central PMCID: PMC2277446.
29. Gallagher JC, Sai A, Templin 2nd T, Smith L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012;156(6):425-37. doi:10.7326/0003-4819-156-6-201203200-00005.
30. Dawodu A, Saadi HF, Bekdache G, Javed Y, Altaye M, Hollis BW. Randomized controlled trial (RCT) of vitamin D supplementation in pregnancy in a population with endemic vitamin D deficiency. J Clin Endocrinol Metab. 2013;98(6):2337-46. doi:10.1210/jc.2013-1154.
31. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. The American journal of clinical nutrition. 2008;87(6):1738-42.
32. Lewis RD, Laing EM, Hill Gallant KM, Hall DB, McCabe GP, Hausman DB, et al. A randomized trial of vitamin d3 supplementation in children: dose-response effects on vitamin d metabolites and calcium absorption. J Clin Endocrinol Metab. 2013;98(12):4816-25. doi:10.1210/jc.2013-2728.
33. Diamond T, Wong YK, Golombick T. Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos Int. 2013;24(3):1101-5. doi:10.1007/s00198-012-1944-7.
34. Drincic A, Fuller E, Heaney RP, Armas LA. 25-hydroxyvitamin d response to graded vitamin d3 supplementation among obese adults. J Clin Endocrinol Metab. 2013;98(12):4845-51. doi:10.1210/jc.2012-4103.
35. Gutierrez OM, Smith KT, Barchi-Chung A, Patel NM, Isakova T, Wolf M. (1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers. Clinical journal of the American Society of Nephrology: CJASN. 2012;7(1):139-45. doi:10.2215/CJN.06240611 PMID: 22246283; PubMed Central PMCID: PMC3265347.
36. Gutierrez OM, Isakova T, Smith K, Epstein M, Patel N, Wolf M. Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. Nephrol Dial Transplant. 2010;25(12):3970-7. doi:10.1093/ndt/gfq316 PMID: 20530498; PubMed Central PMCID: PMC3108369.
37. Turner C, Dalton N, Inaoui R, Fogelman I, Fraser WD, Hampson G. Effect of a 300 000-IU loading dose of ergocalciferol (Vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (FGF-23) in vitamin D insufficiency. J Clin Endocrinol Metab. 2013;98(2):550-6. doi:10.1210/jc.2012-2790.
38. Burnett-Bowie SA, Leder BZ, Henao MP, Baldwin CM, Hayden DL, Finkelstein JS. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. Clin J Am Soc Nephrol. 2012;7(4):624-31. doi:10.2215/CJN.10030911 PMID: 22300739; PubMed Central PMCID: PMC3315336.
39. Hollis BW, Wagner CL. Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab. 2013;98(12):4619-28. doi:10.1210/jc.2013-2653 PMID: 24106283; PubMed Central PMCID: PMC3849670.
40. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013;369(21):1991-2000. doi:10.1056/NEJMoa1306357 PMID: 24256378; PubMed Central PMCID: PMC4030388.